K. Skinningsrud

Suggest Changes
Learn More
The aim of the trial was to evaluate and compare the safety and efficacy of iopentol (Imagopaque®, Nycomed Imaging AS, Oslo, Norway) and amidotrizoate (Peritrast®, Köhler Pharma, Alsbach, Germany),(More)
It has recently been claimed that lack of sodium in nonionic contrast media may increase the risk of ventricular arrhythmias during coronary angiography. Thus, the influence of sodium addition to the(More)
The aim of the study was to evaluate and compare the hemodynamic and electrocardiographic effects following injection of the non-ionic, low- osmolar contrast medium iopentol (Imagopaque® 350, Nycomed(More)
Iopentol (Imagopaque®, Nycomed Imaging AS, Oslo, Norway) 300 mg I/ml was compared with iopromide (Ultravist®, Schering AG, Berlin, Germany) 300 mg I/ml in pediatric angiocardiography in 97 children(More)
  • 1